Godefridus J. Peters

52.7k total citations · 4 hit papers
854 papers, 35.0k citations indexed

About

Godefridus J. Peters is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Godefridus J. Peters has authored 854 papers receiving a total of 35.0k indexed citations (citations by other indexed papers that have themselves been cited), including 451 papers in Molecular Biology, 430 papers in Oncology and 151 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Godefridus J. Peters's work include Colorectal Cancer Treatments and Studies (190 papers), Biochemical and Molecular Research (137 papers) and Cancer therapeutics and mechanisms (102 papers). Godefridus J. Peters is often cited by papers focused on Colorectal Cancer Treatments and Studies (190 papers), Biochemical and Molecular Research (137 papers) and Cancer therapeutics and mechanisms (102 papers). Godefridus J. Peters collaborates with scholars based in Netherlands, United States and Italy. Godefridus J. Peters's co-authors include Herbert M. Pinedo, Elisa Giovannetti, Clive Dickson, Gerrit Jansen, Andries M. Bergman, C.L. van der Wilt, Kees Smid, Paul Noordhuis, Daron Smith and Giuseppe Giaccone and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Godefridus J. Peters

838 papers receiving 34.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluorouracil: biochemistry and pharmacology.

1988 686 citations Herbert M. Pinedo, Godefridus J. Peters profile →
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA

1982 612 citations Godefridus J. Peters et al. profile →
Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.

1994 589 citations Godefridus J. Peters et al. PubMed profile →
MRP3, an organic anion transporter able to transport anti-cancer drugs

1999 521 citations Marcel Kool, Marcel van der Linden et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Godefridus J. Peters Netherlands	92	18.0k	16.5k	5.6k	5.4k	2.8k	854	35.0k
Jan H.M. Schellens Netherlands	91	16.1k 0.9×	22.6k 1.4×	3.7k 0.7×	6.4k 1.2×	2.7k 1.0×	882	41.1k
Susan E. Bates United States	97	20.1k 1.1×	22.9k 1.4×	4.4k 0.8×	2.8k 0.5×	3.5k 1.2×	453	38.5k
Herbert M. Pinedo Netherlands	91	12.1k 0.7×	15.8k 1.0×	3.5k 0.6×	3.9k 0.7×	3.0k 1.1×	571	29.8k
Manfred Dietel Germany	85	12.3k 0.7×	10.9k 0.7×	6.2k 1.1×	5.1k 0.9×	3.0k 1.1×	528	26.0k
Daniel D. Von Hoff United States	91	19.7k 1.1×	23.6k 1.4×	8.3k 1.5×	6.7k 1.2×	4.1k 1.5×	821	44.9k
Elisabeth G.E. de Vries Netherlands	102	14.3k 0.8×	24.1k 1.5×	6.4k 1.1×	7.4k 1.4×	5.2k 1.9×	1.0k	47.8k
Ka‐Fai To Hong Kong	100	13.5k 0.8×	8.9k 0.5×	7.6k 1.4×	6.2k 1.2×	6.2k 2.2×	566	34.7k
Manuel Hidalgo United States	85	12.5k 0.7×	18.5k 1.1×	7.4k 1.3×	7.0k 1.3×	3.1k 1.1×	448	29.7k
Fadlo R. Khuri United States	85	14.7k 0.8×	9.9k 0.6×	4.5k 0.8×	5.6k 1.0×	2.4k 0.8×	486	27.1k
Giampaolo Tortora Italy	69	9.9k 0.6×	13.8k 0.8×	4.8k 0.9×	7.8k 1.4×	2.5k 0.9×	639	24.4k

Countries citing papers authored by Godefridus J. Peters

Since Specialization

Citations

This map shows the geographic impact of Godefridus J. Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Godefridus J. Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Godefridus J. Peters more than expected).

Fields of papers citing papers by Godefridus J. Peters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Godefridus J. Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Godefridus J. Peters. The network helps show where Godefridus J. Peters may publish in the future.

Co-authorship network of co-authors of Godefridus J. Peters

This figure shows the co-authorship network connecting the top 25 collaborators of Godefridus J. Peters. A scholar is included among the top collaborators of Godefridus J. Peters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Godefridus J. Peters. Godefridus J. Peters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steen, Nele Van Der, Christophe Deben, Vanessa Deschoolmeester, et al.. (2016). Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer. World Journal of Clinical Oncology. 7(6). 425–425. 9 indexed citations

Steen, Nele Van Der, Chiara Caparello, Christian Rolfo, et al.. (2016). New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?. OncoTargets and Therapy. Volume 9. 6065–6074. 38 indexed citations

Avan, Amir, Francesco Crea, Elisa Paolicchi, et al.. (2012). Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 11(8). 1735–1746. 80 indexed citations

Gotink, Kristy J., Henk J. Broxterman, Mariëtte Labots, et al.. (2011). Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance. Clinical Cancer Research. 17(23). 7337–7346. 290 indexed citations

Giovannetti, Elisa, et al.. (2010). Drug delivery and drug resistance: EGFR-tyrosine kinase inhibitors in non-small cell lung cancer. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 3(1). 25–32. 2 indexed citations

Giovannetti, Elisa, Niccola Funel, Godefridus J. Peters, et al.. (2010). MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity. Cancer Research. 70(11). 4528–4538. 376 indexed citations

Temmink, Olaf H., Irene V. Bijnsdorp, Henk‐Jan Prins, et al.. (2010). Trifluorothymidine Resistance Is Associated with Decreased Thymidine Kinase and Equilibrative Nucleoside Transporter Expression or Increased Secretory Phospholipase A2. Molecular Cancer Therapeutics. 9(4). 1047–1057. 25 indexed citations

Crea, Francesco, Elisa Giovannetti, Filippo Cortesi, et al.. (2009). Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines. Molecular Cancer Therapeutics. 8(7). 1964–1973. 34 indexed citations

Riel, Jonathan M., Godefridus J. Peters, Richard J. Honeywell, et al.. (2009). A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion. European Journal of Cancer. 45(14). 2519–2527. 16 indexed citations

10.

Wielinga, Peter R., Jan Hendrik Hooijberg, Ietje Kathmann, et al.. (2005). The Human Multidrug Resistance Protein MRP5 Transports Folates and Can Mediate Cellular Resistance against Antifolates. Cancer Research. 65(10). 4425–4430. 107 indexed citations

11.

Wiel, Mark A. van de, José Luís Costa, Kees Smid, et al.. (2005). Expression Microarray Analysis and Oligo Array Comparative Genomic Hybridization of Acquired Gemcitabine Resistance in Mouse Colon Reveals Selection for Chromosomal Aberrations. Cancer Research. 65(22). 10208–10213. 24 indexed citations

12.

Bruin, Michiel de, Kees Smid, Kasper van der Born, et al.. (2004). Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐Phosphate. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1485–1490. 12 indexed citations

13.

Bruin, Michiel de, Kasper van der Born, Frank A.E. Kruyt, et al.. (2003). Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity. British Journal of Cancer. 88(6). 957–964. 62 indexed citations

14.

Ackland, Stephen P., Philip Beale, & Godefridus J. Peters. (2003). Thymidylate synthase inhibitors. PubMed. 20. 1–28. 12 indexed citations

15.

Wilt, C.L. van der, Judith R. Kroep, Andries M. Bergman, et al.. (2002). The Role of Deoxycytidine Kinase in Gemcitabine Cytotoxicity. Advances in experimental medicine and biology. 486. 287–290. 25 indexed citations

16.

Kool, Marcel, Marcel van der Linden, Marcel de Haas, et al.. (1999). MRP3, an organic anion transporter able to transport anti-cancer drugs. Proceedings of the National Academy of Sciences. 96(12). 6914–6919. 521 indexed citations breakdown →

17.

Triest, Baukelien van & Godefridus J. Peters. (1999). Thymidylate Synthase: A Target for Combination Therapy and Determinant of Chemotherapeutic Response in Colorectal Cancer. Oncology. 57(3). 179–194. 60 indexed citations

18.

Bergman, Andries M., Herbert M. Pinedo, Gijsbert Veerman, Catharina M. Kuiper, & Godefridus J. Peters. (1998). Increased Sensitivity to Gemcitabine of P-gP and MRP Overexpressing Human Non-Small Cell Lung Cancer Cell Lines. Advances in experimental medicine and biology. 431. 591–594. 10 indexed citations

19.

Beenken, Samuel W., Pei‐Hsin Huang, Marty T. Sellers, et al.. (1994). Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.. PubMed. 19. 270–7. 15 indexed citations

20.

López‐López, Rafael, et al.. (1994). Effect of suramin on adenylate cyclase and protein kinase C.. PubMed. 9(4). 279–90. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact